While everyone is discussing are we in an AI bubble or not, Harvard is teaching how to invest in these irrational times.
Yosemite, which funds startups and researchers focused on the disease, is targeting a total of $350 million for its second fund from high-powered investors like pharma giant Amgen and hospital Memorial Sloan Kettering.
In this week’s edition of The Prototype, we look at how a new discovery could lead to unsinkable ships, the billions invested in AI “neolabs” and more.
In this week’s edition of InnovationRx, In this week’s edition of InnovationRx, we look at the health risks of winter storms, a new Korean weight loss drug billionaire, a biotech using AI for rare diseases, and more.
Europe-based venture fund 2150 raised the money to invest in climate tech startups that help solve cities’ carbon footprint.
Silicon Valley’s startup culture is changing—996 schedules, sober founders, and relentless focus are replacing the era of “work hard, play hard.”
China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the industry—and Washington—are rethinking the risks.
European startup funding is finding its rhythm in 2026. Here’s where you’ll find real investors, real founders, and real momentum in 2026.
In this week’s edition of The Prototype, we look at the booming space industry, better space weather forecasts, the first medical evacuation from space and more.
Tabular foundation models are the next major unlock for AI adoption, especially in industries sitting on massive databases of structured, siloed, and confidential data.